Literature DB >> 19553061

Buprenorphine maintenance treatment in a primary care setting: outcomes at 1 year.

Janet M Soeffing1, L David Martin, Michael I Fingerhood, Donald R Jasinski, Darius A Rastegar.   

Abstract

The purposes of this study were to assess outcomes of patients prescribed buprenorphine at a primary care practice and to identify factors associated with favorable outcomes. All 255 patients given at least one prescription for buprenorphine between August 2003 and September 1, 2007, at a primary care practice in Baltimore were included. Data regarding demographics and comorbidities were collected retrospectively. Patients were classified as "opioid-positive" or "opioid-negative" each month based on patient report, urine toxicology, and provider assessment. After 12 months, 145 (56.9%) patients remained in treatment, and 64.7% of their months were opioid-negative. Patients using heroin were less likely to be opioid-negative, whereas those using prescription opioids were more likely to be opioid-negative. Polysubstance use was associated with increased treatment retention. The prescription of buprenorphine for opioid dependence treatment can be incorporated into primary care practice, and many patients, including polysubstance users, benefit from this treatment.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19553061     DOI: 10.1016/j.jsat.2009.05.003

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  51 in total

Review 1.  Update in addiction medicine for the generalist.

Authors:  Adam J Gordon; Hillary V Kunins; Darius A Rastegar; Jeanette M Tetrault; Alexander Y Walley
Journal:  J Gen Intern Med       Date:  2010-08-10       Impact factor: 5.128

2.  Prevalence of mood and substance use disorders among patients seeking primary care office-based buprenorphine/naloxone treatment.

Authors:  Jonathan D Savant; Declan T Barry; Christopher J Cutter; Michelle T Joy; An Dinh; Richard S Schottenfeld; David A Fiellin
Journal:  Drug Alcohol Depend       Date:  2012-07-06       Impact factor: 4.492

3.  Emergency Department-Initiated Buprenorphine for Opioid Dependence with Continuation in Primary Care: Outcomes During and After Intervention.

Authors:  Gail D'Onofrio; Marek C Chawarski; Patrick G O'Connor; Michael V Pantalon; Susan H Busch; Patricia H Owens; Kathryn Hawk; Steven L Bernstein; David A Fiellin
Journal:  J Gen Intern Med       Date:  2017-02-13       Impact factor: 5.128

4.  Emerging adult age status predicts poor buprenorphine treatment retention.

Authors:  Zev Schuman-Olivier; Roger D Weiss; Bettina B Hoeppner; Jacob Borodovsky; Mark J Albanese
Journal:  J Subst Abuse Treat       Date:  2014-05-20

5.  A pilot study of mindful body awareness training as an adjunct to office-based medication treatment of opioid use disorder.

Authors:  Cynthia J Price; Joseph O Merrill; Rachelle L McCarty; Kenneth C Pike; Judith I Tsui
Journal:  J Subst Abuse Treat       Date:  2019-05-23

6.  Is residential treatment effective for opioid use disorders? A longitudinal comparison of treatment outcomes among opioid dependent, opioid misusing, and non-opioid using emerging adults with substance use disorder.

Authors:  Zev Schuman-Olivier; M Claire Greene; Brandon G Bergman; John F Kelly
Journal:  Drug Alcohol Depend       Date:  2014-09-18       Impact factor: 4.492

7.  A randomized controlled trial of buprenorphine for probationers and parolees: Bridging the gap into treatment.

Authors:  Michael S Gordon; Frank J Vocci; Faye Taxman; Marc Fishman; Bikash Sharma; Thomas R Blue; Kevin E O'Grady
Journal:  Contemp Clin Trials       Date:  2019-02-20       Impact factor: 2.226

8.  Buprenorphine for prescription opioid addiction in a patient with depression and alcohol dependence.

Authors:  Marc J Fishman; Li-Tzy Wu; George E Woody
Journal:  Am J Psychiatry       Date:  2011-07       Impact factor: 18.112

9.  Debating Medical Utility, Not Futility: Ethical Dilemmas in Treating Critically Ill People Who Use Injection Drugs.

Authors:  Stephen R Baldassarri; Ike Lee; Stephen R Latham; Gail D'Onofrio
Journal:  J Law Med Ethics       Date:  2018-06       Impact factor: 1.718

10.  Predictors of early dropout in outpatient buprenorphine/naloxone treatment.

Authors:  David E Marcovitz; R Kathryn McHugh; Julie Volpe; Victoria Votaw; Hilary S Connery
Journal:  Am J Addict       Date:  2016-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.